Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose ABT-378/Ritonavir in Treatment-Experienced HIV Patients
NCT00038636Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Sep 2000
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Abbott Laboratories. Started Sep 2000; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00038636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038636.